Article Details

Lilly's baricitinib delivered high rates of hair regrowth for adolescents with severe alopecia ...

Retrieved on: 2025-03-10 17:16:49

Tags for this article:

Click the tags to see associated articles and topics

Lilly's baricitinib delivered high rates of hair regrowth for adolescents with severe alopecia .... View article details on hiswai:

Summary

The article discusses a study on baricitinib, a JAK inhibitor, showing promising results for treating severe alopecia areata in adolescents. This relates to the key concept of COVID by highlighting baricitinib's potential anti-inflammatory uses, initially developed for conditions such as COVID-19 and rheumatoid arthritis. Tags connect the research to autoimmune-related hair loss, including its approval in the US and Japan for hair diseases.

Article found on: www.marketscreener.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up